Aragen appoints Subodh Deshmukh as CEO Aragen Biosciences and Head of Development Services

Aragen Life Sciences Limited (“Aragen”), a global contract research, development, and manufacturing organization (CRDMO), today announced the appointment of Dr. Subodh Deshmukh as CEO of Aragen Bioscience and President of Development Services. Dr. Deshmukh joins Aragen from Zymergen, USA where he was the Chief Development Officer and will be based in the Morgan Hill, California campus of Aragen. Aragen Bioscience is the US-subsidiary of Aragen and provides research and development services for biologics.

Aragen appoints Subodh Deshmukh as CEO Aragen Biosciences and Head of Development Services